Rhodium(I) complexes of the conformationally rigid IBioxMe4Ligand : preparation of mono-, bis-, and tris-ligated NHC complexes by Chaplin, Adrian B.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Chaplin, Adrian B. (2014) Rhodium(I) complexes of the conformationally rigid 
IBioxMe4Ligand: preparation of mono-, bis-, and tris-ligated NHC complexes. 
Organometallics, 33 (12). pp. 3069-3077. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/65623  
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of 
the University of Warwick available open access under the following conditions.  
Copyright © and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.  To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility 
before being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-
for profit purposes without prior permission or charge.  Provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way. 
 
Publisher’s statement: 
This document is the Accepted Manuscript version of a Published Work that 
appeared in final form in Organometallics, copyright © American Chemical Society 
after peer review and technical editing by the publisher.  
 
To access the final edited and published work see: 
http://dx.doi.org/10.1021/om500332n  
 
A note on versions: 
The version presented here may differ from the published version or, version of 
record, if you wish to cite this item you are advised to consult the publisher’s version.  
Please see the ‘permanent WRAP URL’ above for details on accessing the published 
version and note that access may require a subscription. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
	 1	
Revised	manuscript	om-2014-00332n	
	
Rhodium(I)	Complexes	of	the	Conformationally	Rigid	IBioxMe4	Ligand:	Preparation	
of	Mono-,	Bis-	and	Tris-Ligated	NHC	Complexes	
	
Adrian	B.	Chaplin	
	
Department	of	Chemistry,	University	of	Warwick,	Gibbet	Hill	Road,	Coventry	CV4	7AL,	UK.		
Email:	a.b.chaplin@warwick.ac.uk	 	
	
Abstract	
The	 preparation	 and	 characterisation	 of	 a	 series	 of	mono-,	 bis-	 and	 tris-ligated	 rhodium(I)	 complexes	 of	
Glorius’	 conformationally	 rigid	bioxazoline	derived	N-heterocyclic	 carbene	 ligand	 IBioxMe4	are	described.	
Through	 reaction	 of	 [Rh(COE)2Cl]2	 (COE	 =	 cis-cyclooctene)	with	 isolated	 IBioxMe4,	 [Rh(IBioxMe4)(COE)Cl]2	
(1),	trans-[Rh(IBioxMe4)2(COE)Cl]	 (2)	and	[Rh(IBioxMe4)3Cl]	 (3)	were	each	 isolated	by	careful	choice	of	the	
reaction	 conditions.	 Further	 substitution	 and	 salt	 metathesis	 reactions	 of	 1	 –	 3	 were	 investigated	 and	
derivatives	 containing	 CO,	 norbornadiene	 and	 cyclopentadienyl	 ancillary	 ligands	 were	 readily	 isolated.	
Notably,	halide	abstraction	from	2	and	3	using	Na[BArF4]	(ArF	=	3,5-C6H3(CF3)2)	resulted	in	the	formation	of	
low	coordinate	T-shaped	cis-[Rh(IBioxMe4)2(COE)][BArF4]	(9)	and	[Rh(IBioxMe4)3][BArF4]	(11).	The	solid-state	
structures	 of	 2,	 9	 and	 11	 each	 feature	 IBioxMe4	 ligands	 that	 bind	 unusually	 with	 tilted	 coordination	
geometries.		
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Introduction	
With	generally	stronger	σ-donating	characteristics	and	orthogonal	steric	profiles	 to	phosphine	 ligands,	N-
heterocyclic	 carbenes	 (NHCs)	 have	 quickly	 emerged	 as	 a	 powerful	 class	 of	 carbon-based	 ligand	 in	
organometallic	chemistry	and	catalysis.1	While	in	the	majority	of	applications	spectator	roles	are	intended,	
intramolecular	 C(sp3)–H	 bond	 activation	 reactions	 of	 coordinated	 NHC	 ligands	 are	 increasingly	 being	
observed	when	partnered	with	reactive	late	transition	metal	fragments.2	Examples	include	activation	of	the	
N-aryl	 and	 alkyl	 substituents	 of	 common	 NHC	 ligands:	 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene	
(IiPr2Me2),	 1,3-bis-tert-butylimidazol-2-ylidene	 (ItBu),	 1,3-bis-mesitylimidazol-2-ylidene	 (IMes),	 and	 1,3-
bis(2,6-diisopropylphenyl)-imidazol-2-ylidene	 (IPr),	 amongst	 others	 (Chart	 1).	3,4,5,6,7	The	 IMes	 ligand	 has	
even	 been	 shown	 to	 support	 double	 cyclometalation 8 	and	 subsequent	 reactivity	 of	 NHC-based	
metallocycles	 can	 lead	 to	 alkyl	 dehydrogenation.6a,7,9	However,	 although	 cyclometalation	 reactions	 are	of	
interest	 in	 their	 own	 right, 10 	they	 can	 represent	 unwanted	 and	 potentially	 detrimental	 reactivity	
characteristics	of	NHC	based	metal	complexes.	
	
Chart	1:	Cyclometalated	NHC	topologies.	
	
Scheme	1:	Hypothesised	reactivity	modulation.	
	
	
Recognising	that	substituent	flexibility,	particularly	rotation	about	N-aryl/alkyl	bonds,	is	a	key	prerequisite	
for	cyclometalation	reactions	of	NHC	ligands,	conformationally	rigid	analogues	were	targeted	as	a	means	to	
attenuate	such	reactivity,	whilst	retaining	the	desirable	electronic	and	steric	properties	of	the	ligand	class.	
With	such	features	 in	mind,	bioxazoline-derived	NHC	ligands	(IBiox)	developed	by	Glorius	and	co-workers	
were	 identified	 from	 the	 literature.11, 12	IBiox	 ligands	 are	 particularly	 notable	 for	 their	 application	 in	
palladium	 catalysed	 cross	 coupling	 reactions,	 although	 their	 coordination	 chemistry	 has	 not	 been	widely	
explored.	 Given	 the	 structural	 similarity	with	 IiPr2Me2	 and	 ItBu,	 the	 tetramethyl-substituted	 IBiox	 ligand,	
IBioxMe4,	 was	 chosen	 for	 investigation	 (Scheme	 1).	 With	 a	 view	 of	 contrasting	 the	 cyclometalation	
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processes	 observed	 by	Nolan	 and	 others	 in	 rhodium	 complexes	 of	 ItBu,3,4	 the	 coordination	 chemistry	 of	
IBioxMe4	with	 rhodium	was	 targeted	and	a	 range	of	mono-,	bis-	and	 tris-ligated	derivatives	are	 reported	
herein.	Some	aspects	of	this	chemistry	were	published	as	a	communication	(i.e.	tris-NHC	complexes	11	and	
12).13				
	
Results	and	discussion	
Synthesis	of	free	carbene	
The	 target	 imidazolium	 pro-ligand	 IBioxMe4.HOTf	 was	 synthesised	 in	 four	 steps,	 from	 commercially	
available	 2-amino-2-methyl-propanol	 and	 diethyloxalate,	 as	 previously	 described	 by	 Glorius	 and	 co-
workers.11	The	corresponding	free	carbene	ligand	was	readily	formed	by	reaction	of	the	pro-ligand	with	the	
strong	hindered	base	K[N(SiMe3)2]	in	THF	(Scheme	2).13	In	this	manner	IBioxMe4	was	isolated	in	80%	yield,	
following	removal	of	volatiles	in	vacuo	and	extraction	with	pentane,	and	stored	under	argon	in	a	glove	box.	
Satisfactory	microanalyses	were	obtained	and	the	free	carbene	was	fully	characterised	in	C6D6	solution	by	
NMR	 spectroscopy.	 C2v	 symmetry	 is	 observed	 in	 solution	 with	 the	 carbene	 resonance	 at	 190.1	 ppm,	
significantly	downfield	from	the	pro-ligand	(112.4	ppm)	and	consistent	with	other	systems.12b,14	
	
Scheme	2:	Preparation	of	IBioxMe4.	
	
	
Reaction	of	IBioxMe4	with	[Rh(COE)2Cl]2	
Following	 the	 procedure	 of	 Nolan	 and	 co-workers,3	 reaction	 of	 IBioxMe4	 with	 the	 rhodium(I)	 precursor	
[Rh(COE)2Cl]2	 (COE	 =	 cis-cyclooctene)	 in	 pentane	 resulted	 in	 the	 formation	 of	 dimeric	 chloro-bridged	
rhodium(I)	 complex	 [Rh(IBioxMe4)(COE)Cl]2	1,	which	was	 isolated	 in	 good	 yield	 following	 recrystallisation	
from	benzene–heptane	(66%,	Scheme	3).	Coordination	of	the	COE	and	carbene	ligands	is	confirmed	by	the	
observation	of	13C	doublet	resonances	at	δ	60.4	(1JRhC	=	17	Hz)	and	δ	158.3	(1JRhC	=	59	Hz),	respectively,	by	
NMR	 spectroscopy.	 Likewise,	 coordinated	 alkene	 protons	 are	 observed	 at	 2.97	 ppm	 as	 an	 integral	 2H	
multiplet	in	the	1H	NMR	spectrum.	These	data	are	in	good	agreement	with	those	of	the	ItBu	analogue	(A)3	
and	 related	dimeric	complexes	 [Rh(NHC)(H2C=CH2)Cl]2	 (NHC	=	 IMes,	SIMes,	 IPr,	SIPr,	 ItBu	 (B))15	previously	
prepared	by	Crudden	and	co-workers.4		
	
Scheme	3:	Preparation	of	dimeric	1.	
	
	
Isolated	1	 is	 stable	 in	 solution,	 showing	no	apparent	 reaction	after	7	days	 in	C6D6	 solution	 (293	K)	by	 1H	
NMR	spectroscopy.	While	A	has	also	been	reported	to	be	stable	 in	benzene	solution,3	 in	 the	presence	of	
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excess	 ItBu	 sequential	 formation	 of	monomeric	 cyclometalated	 derivatives	C	 and	D	 occurs;	where	 these	
complexes	 contain	 one	 and	 two	 cyclometalated	 ItBu	 ligands	 (ItBu’),	 respectively	 (Chart	 2).	 Addition	 of	
excess	 IBioxMe4	to	 isolated	1	 in	C6D6	similarly	resulted	 in	 fragmentation	of	 the	chloride	bridge.	However,	
instead	of	intramolecular	activation	of	the	NHC	ligand,	mixtures	of	the	bis-	and	tris-NHC	complexes	trans-
[Rh(IBioxMe4)2(COE)Cl]	(2)	and	[Rh(IBioxMe4)3Cl]	(3)	were	obtained;	the	later	almost	completely	insoluble	in	
benzene	 (Scheme	 4).	 Following	 this	 reaction	 in	 situ	 by	 NMR	 spectroscopy	 (C6D6,	 293	 K)	 revealed	 a	
significant	rate	dependence	on	the	concentration	of	the	NHC	ligand.	With	4	equivalents	IBioxMe4	the	initial	
rate	for	the	disappearance	of	1	was	ca	3.7	×	10-6	mol·L-1s-1,	which	increased	to	ca	8.2	×	10-6	mol·L-1s-1	when	
using	8	equivalents	of	the	ligand.	After	90%	consumption	of	1,	the	resulting	ratios	of	2:3	were	5.8	and	4.5,	
respectively.	 These	 data	 indicate	 approximate	 first	 order	 dependence	 on	 [IBioxMe4]	 and	 a	 faster	 rate	 of	
formation	 for	 2	 relative	 to	 3.	 Given	 that	 reaction	 between	 2	 and	 IBioxMe4	 to	 give	 3	 is	 two	 orders	 of	
magnitude	slower	than	the	reaction	of	1	with	IBioxMe4	(vide	infra),	the	most	plausible	mechanism	for	this	
reaction	 involves	bifurcated	(associative)	 ligand	substitution	chemistry	of	1	 (Scheme	4);	a	suggestion	that	
invokes	 the	 presence	 of	 transient	 (unobserved)	 bis-NHC	 complex,	 cis-[Rh(IBioxMe4)2(COE)Cl]	 or	
[Rh(IBioxMe4)2Cl]2,	 in	 the	 formation	 of	 3.	 Throughout	 these	 in	 situ	 reactions	 no	 evidence	 for	 ligand	
cyclometalation	was	observed	supporting	the	hypothesised	reactivity	attenuation	of	the	conformationally	
rigid	ligand	in	comparison	to	ItBu.	A	feature	of	the	IBioxMe4	complexes	further	contrasted	by	the	reported	
reactivity	 of	 isolated	 B,	 which	 undergoes	 spontaneous	 intramolecular	 activation	 of	 the	 NHC	 ligand,	
resulting	in	formation	of	the	rhodium(III)	dimer	[Rh(ItBu’)(CH2CH3)Cl]2,	C	and	metallic	rhodium.4		
	
Chart	2:	Cyclometalated	rhodium	complexes	of	ItBu.	
	
Scheme	4:	Reaction	of	1	with	IBioxMe4.	
	
	
Complexes	2	 and	3	 are	most	conveniently	prepared	by	direct	 reaction	between	 [Rh(COE)2Cl]2	and	excess	
IBioxMe4	 (4.6	 eqv.)	 in	 benzene	 and	 were	 obtained	 in	 this	 way	 with	 isolated	 yields	 of	 47%	 and	 24%	
respectively;	the	insolubility	of	3	enabled	easy	separation	of	the	two	complexes.	The	structures	of	2	and	3	
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were	determined	by	X-ray	 crystallography	 (Figure	1)	 and	 corroborated	 in	 solution	by	NMR	spectroscopy.	
Both	complexes	adopt	the	expected	square	planar	geometries,	although	for	2	(with	two	crystallographically	
independent,	but	structurally	similar	complexes)	there	is	a	significant	degree	of	distortion:	the	C11-Rh1-C26	
angle	 deviating	 from	 linearity	 (167.49(7)º;	 167.47(7)º	 for	 Rh1A	 equivalent).	 Interestingly,	 one	 of	 the	
IBioxMe4	 ligands	 binds	 unusually,	 pitching	 significantly	 out	 of	 plane	 as	 quantified	 by	 a	 non-linear	 NHC	
centroid−CNCN−Rh	 angle	 (ΘNHC)16	of	 156.50(14)º	 (164.72(13)º	 for	 Rh1A	 equivalent).	 Such	 large	 deviations	
from	planar	coordination	are	rare	in	transition	metal	complexes,17,18	and	notably	more	pronounced	in	2	in	
comparison	to	related	[Rh(SIMes)(PPh3)(H2C=CH2)Cl]	(ΘNHC	=	170.5º)4,	trans-[Rh(SIMes)2LCl]	(L	=	N2,	O2,	CO	
(E);	ΘNHC	=	177.4	–	178.5º)19	and	trans-[Ir(NHC)2(COE)Cl]	(ΘNHC	=	169.6	–	178.4º).20	This	tilting	is	attributed	to	
steric	interactions	between	the	NHC	and	the	coordinated	COE	ligands	and	born	out	through	the	presence	
of	close	{COE}CH2···H3C{IBioxMe4}	contacts	of	ca	3.6	Å	(sum	of	Van	der	Waal	radii	=	3.4	Å).	Moreover	in	line	
with	this	reasoning,	essentially	planar	IBioxMe4	coordination	is	observed	when	COE	is	replaced	with	a	less	
bulky	ancillary	ligand	(i.e.	7,	vide	infra).	Complex	3	is	an	NHC	analogue	of	Wilkinson’s	catalyst,	examples	of	
which	have	been	previously	reported	by	Lappert	et	al.21	The	IBioxMe4	ligands	twist	in	a	helical	fashion	and	
all	ΘNHC	are	greater	than	175º	in	the	solid-state	structure	of	3.	
	
	
Figure	1:	Solid-state	structures	of	2	(left)	and	3	(right).	Thermal	ellipsoids	for	selected	atoms	are	drawn	at	
the	50%	probability	 level;	most	hydrogen	atoms	are	omitted	for	clarity;	only	one	of	the	two	independent	
molecules	shown	for	each	complex	(Z’	=	2	for	both	2	and	3).	Selected	bond	lengths	(Å)	and	angles(º):	2	–	
Rh1-Cl2,	 2.4231(5);	 Rh1-C3,	 2.125(2);	 Rh1-C4,	 2.117(2);	 Rh1-C11,	 2.100(2);	 Rh1-C26,	 2.026(2);	 C3-C4,	
1.411(3);	 Cl2-Rh1-Cnt(C3,C4),	 175.10(2);	 C11-Rh1-C26,	 167.49(7);	 ΘNHC(@C11),	 156.50(14);	 ΘNHC(@C26),	
172.98(13);	ΘNHC(@C11A),	 164.72(13);	ΘNHC(@C26A),	 170.1(2);	3	 –	 Rh1-Cl2,	 2.4224(14);	 Rh1-C3,	 2.046(5);	
Rh1-C18,	2.060(5);	Rh1-C33,	2.016(5);	Cl2-Rh1-C33,	177.3(2);	C3-Rh1-C18,	169.2(2);	all	ΘNHC	>	175.		
	
To	establish	if	2	is	a	kinetically	relevant	intermediate	in	the	formation	of	3	from	1,	in	situ	NMR	experiments	
were	carried	out	involving	reaction	of	2	with	excess	IBioxMe4	(2	and	4	eqv.)	in	C6D6	(293	K).	A	slow	reaction	
was	observed,	 involving	substitution	of	 the	COE	 ligand	 independent	of	 [IBioxMe4],	with	an	 initial	 rate	 for	
the	disappearance	of	2	of	ca	7.0	×	10-8	mol·L-1s-1	and	approximate	half-life	of	82	h.	These	data	suggest	a	
dissociative	mechanism	for	the	substitution	of	the	COE	ligand	and	clearly	show	the	formation	of	3	via	2	 is	
not	 a	 kinetically	 relevant	 pathway	 in	 the	 reaction	 of	 dimeric	 1	 with	 IBioxMe4.	 Consistent	 with	 this	
suggestion,	 isolated	 2	 slowly	 lost	 COE	 in	 solution	 (ca	 15%	 decomposition	 after	 24	 h	 in	 C6D6	 at	 293	 K).	
Complex	 3	 is	 observed	 during	 the	 decomposition;	 however,	 the	 other	 species	 involved	 have	 eluded	
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identification	so	far.		
Coordination	chemistry	of	1	–	3		
Seeking	 to	 further	 explore	 the	 coordination	 chemistry	 of	 these	 rhodium(I)	 IBioxMe4	 complexes,	
incorporation	 of	 other	 carbon	 based	 ancillary	 ligands	was	 targeted.	 To	 this	 end,	 reactions	 of	1	with	 CO,	
norbornadiene	(NBD)	and	Na[Cp]	were	investigated	(Scheme	5).	Under	an	atmosphere	of	CO,	1	was	rapidly	
(<	 10	 min)	 and	 quantitatively	 (by	 NMR	 spectroscopy)	 converted	 to	 the	 bis-carbonyl	 complex	 cis-
[Rh(IBioxMe4)(CO)2Cl]	 4	 (solid-state	 structure	 in	 Figure	 2).	 Complexes	 of	 the	 formulation	 cis-
[M(NHC)(CO)2Cl]	 (M	=	Rh,	 Ir)	 have	been	widely	used	 to	probe	 the	electronic	and	 steric	 characteristics	of	
NHC	 ligands	 (Table	1).22		 In	particular,	 these	complexes	allow	the	determination	of	 the	Tolman	electronic	
parameter	 (TEP)23	for	 the	 NHC	 ligand	 from	 the	 carbonyl	 stretching	 frequencies	 of	 cis-[M(NHC)(CO)2Cl],	
avoiding	the	need	to	prepare	toxic	nickel	adducts.24,25	Using	this	approach	the	calculated	TEP	for	IBioxMe4	
using	 4	 (2053	 cm-1)	 is	 in	 good	 agreement	 with	 that	 determined	 using	 the	 previously	 reported	 iridium	
analogue	cis-[Ir(IBioxMe4)(CO)2Cl]	(2052	cm-1)11	and	both	are	marginally	larger	in	magnitude	than	those	of	
IiPr2Me2	 (2051	 cm-1)	 and	 ItBu	 (2050	 cm-1),	 inline	 with	 the	 presence	 of	 the	 electronegative	 oxygen	
substituents.	The	steric	characteristics	of	IBioxMe4	have	also	been	quantified	through	measurement	of	it’s	
percentage	buried	volume	(%Vbur)	using	the	solid-state	structure	of	4	for	the	relevant	calculation.26,27	Steric	
bulk	 increases	 in	 the	order	 IiPr2Me2	<	 IBioxMe4	<	ItBu,	with	the	%Vbur	of	 IBioxMe4	 (32.0)	notably	similar	 to	
that	of	aryl	substituted	IMes	(33.8)	
	
Scheme	5:	Preparation	of	4	–	6.	
	
	
Figure	2:	Solid-state	structures	of	4	(left)	and	5	(right).	Thermal	ellipsoids	for	selected	atoms	are	drawn	at	
the	 50%	 probability	 level;	 most	 hydrogen	 atoms	 are	 omitted	 for	 clarity.	 Selected	 bond	 lengths	 (Å)	 and	
angles(º):	 4	 –	 Rh1-Cl2,	 2.3519(5);	 Rh1-C3,	 1.830(2);	 Rh1-C5,	 1.897(2);	 Rh1-C7,	 2.069(2);	 ΘNHC(@C7),	
178.97(13);	 5	 –	 Rh1-Cl2,	 2.3642(15);	 Rh1-C3,	 2.048(6);	 Rh1-	 C18,	 2.197(6);	 Rh1-C19,	 2.182(6);	 Rh1-C21,	
2.098(6);	Rh1-C22,	2.105(6);	ΘNHC(@C3),	177.2(4).	
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Table	1:	Steric	and	electronic	properties	of	NHC	ligands	derived	from	cis-[M(NHC)(CO)2Cl]	
M	 NHC	 ν(CO)	[CH2Cl2]	/cm-1		 TEP	[calc.]a	(expt.)	/cm-1	 %Vbur	b	 Ref.	
Rh	 IBioxMe4	 2081	 2000	 2053		 32.0	 This	work	
Ir	 IBioxMe4	 2066	 1982	 2052	 -	 11	
Rh	 IiPr2Me2	 2076	 1996	 2051	 28.0c	 28	
Ir	 ICyd	 2065	 1981	
2051	(2050)29	
28.1	 25	
Ir	 ItBu	 2065	 1980	 2050	 37.6	 25	
Ir	 IMes	 2066	 1980	 2051	(2051)29	 33.8	 25	
a	Tolman	electronic	parameter	calculated	from	regression	using	the	average	ν(CO)	value.22	b	Calculated	
using	SambVca	(sphere	radius	=	3.5,	distance	from	centre	of	sphere	=	2.0,	mesh	spacing	=	0.5,	hydrogens	
omitted,	bondi	radii	scaled	by	1.17).27	c	Estimated	from	X-ray	structure	of	[Rh(IiPr2Me2)(COD)(OH)].30		d	ICy	=	
=	1,3-bis-cyclohexylimidazol-2-ylidene.	
	
In	comparison	to	the	reaction	with	CO,	the	reaction	between	1	and	NBD	to	afford	[Rh(IBioxMe4)(NBD)Cl]	5	
occurred	significantly	slower,	with	an	approximate	half-life	of	3.6	h.	 Indeed,	5	was	more	readily	prepared	
by	reaction	of	IBioxMe4	with	the	dimeric	rhodium(I)	precursor	[Rh(NBD)Cl]2	(88%	isolated	yield).	The	solid-
state	structure	of	5	(Figure	2)	resembles	that	of	4	and	is	otherwise	unremarkable,	as	are	NMR	data.	Placing	
5	 under	 an	 atmosphere	 of	 CO	 quantitatively	 afforded	 4	 (by	 NMR	 spectroscopy)	 alongside	 free	 NBD	 –	
therefore	offering	an	alternative	synthetic	route	to	the	bis-carbonyl	compound	(Scheme	5).	
Cyclopentadienyl	 complex	 [Rh(IBioxMe4)(Cp)(COE)]	 (6)	 resulted	 from	 salt	metathesis	 of	1	 in	 CH2Cl2	 using	
Na[Cp]	and	was	isolated	in	good	yield	(72%).	Coordination	of	the	hydrocarbon	ligands	are	apparent	by	the	
presence	of	a	5H	and	2H	signals	at	δ	5.11	and	2.11	together	with	characteristic	doublets	in	the	13C{1H}	NMR	
spectrum	at	δ	86.2	 (1JRhC	 =	3	Hz)	 and	53.1	 (1JRhC	 =	17	Hz)	 for	 the	 [Cp]–	 and	COE	 ligands,	 respectively;	 the	
carbene	signal	was	observed	at	δ	159.7	(d,	1JRhC	=	66	Hz).	Surprisingly,	few	examples	of	non-chelating	NHC	
rhodium(I)	 cyclopentadienyl	 complexes	 are	 known;	 [Rh(IMes)(C5R5)(H2C=CH2)]	 (R	 =	 H	 (F),	 Me)	 and	
[Rh(SIMe)(Cp)(CO)]	 (SIMe	 =	 1,3-bis-methylimidazolin-2-ylidene)	 being	 the	 only	 precedents.31	The	 NMR	
characteristics	of	6	are	in	agreement	with	those	reported	for	F;	δC5H5	84.7	(d,	1JRhC	=	4	Hz),	δC2H4	24.3	(d,	1JRhC	
=	16	Hz)	and	δNCN	185.0	(1JRhC	=	70	Hz).	
Reaction	of	bis-NHC	2	with	 carbon	monoxide	 readily	 affords	 trans-[Rh(IBioxMe4)2(CO)Cl]	7,	which	 can	be	
substituted	 further	with	 carbon	monoxide	 in	 the	presence	of	Na[BArF4]	 (ArF	 =	3,5-C6H3(CF3)2),	 as	 a	halide	
abstracting	 agent,	 to	 give	 the	 bis-carbonyl	 complex	 trans-[Rh(IBioxMe4)2(CO)2][BArF4]	 8	 (Scheme	 6).	 The	
structures	 of	 both	 carbonyl	 complexes	 were	 established	 through	 a	 combination	 of	 NMR	 and	 IR	
spectroscopy	 (C2v,	 7;	 D2h,	 8),	 alongside	 crystallographic	 characterisation	 (Figure	 3).	 	 A	 more	 upfield	 13C	
resonance	for	the	NHC	(141.0	vs.	160.5	ppm),	reduced	carbonyl	1JRhC	coupling	constant	(64	vs.	82	Hz)	and	
higher	 carbonyl	 stretching	 frequency	 (2024	 vs.	 1942	 cm-1)	 are	 observed	 for	 8	 in	 comparison	 to	 7,	 fully	
consistent	 with	 the	 more	 electron	 deficient	 nature	 of	 the	 metal	 centre.	 While	 there	 are	 a	 number	 of	
examples	of	complexes	of	the	formulation	[Rh(NHC)2(CO)Cl]	(e.g.	E),5x,19,	28,32	there	is	only	one	non-chelating	
precedent	for	8	to	the	author’s	knowledge.33		
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Scheme	6:	Reactions	of	bis-IBioxMe4	complexes.a	
	
a	[BArF4]–	anions	omitted	for	clarity	
	
	
Figure	3:	Solid-state	structures	of	7	–	10	(left	to	right).	Thermal	ellipsoids	for	selected	atoms	are	drawn	at	
the	 50%	 probability	 level;	 most	 hydrogen	 atoms,	 minor	 disordered	 components,	 anions	 and	 solvent	
molecules	 are	 omitted	 for	 clarity;	 only	 one	 of	 the	 two	 independent	 molecules	 shown	 for	 9	 (Z’	 =	 2);	
symmetry	operations	 -x,-y,-z	 (7)	and	2-x,+y,3/2-z	 (10)	were	used	 to	generate	 the	started	atoms.	Selected	
bond	 lengths	 (Å)	 and	 angles(º):	 7	 –	 Rh1-Cl2,	 2.386(2);	 Rh1-C3*,	 1.807(6);	 Rh1-C5,	 2.050(2);	 C5-Rh1-C5*	
180.00;	ΘNHC(@C5),	176.8(2);	8	–	Rh1-C2,	1.910(3);	Rh1-C4,	1.917(3);	Rh1-C6,	2.063(2);	Rh1-C21,	2.061(2);	
C6-Rh1-C21,	177.53(9);	all	ΘNHC(NHC)	>	175;	9	–	Rh1-C2,	2.196(14);	Rh1-C3,	2.123(14);	Rh1-C4,	2.56(2);	Rh1-
C10,	 2.099(14);	 Rh1-C25,	 1.971(15);	 all	 other	 Rh1-C	 >	 3.0;	 C10-Rh1-C25,	 100.5(6);	 ΘNHC(@C10),	 168(1);	
ΘNHC(@C25),	 178.5(12);	 Rh1A-C4A,	 2.94(2);	 all	 other	 non-coordinated	 Rh1A-C	 >	 3.0;	 ΘNHC(@C10A),	
168.4(11);	ΘNHC(@C25A),	177.8(13);	10	–	Rh1-C2,	2.163(2);	Rh1-C4,	2.159(2);	Rh1-C6,	2.121(2);	C6-Rh1-C6*,	
101.51(9);	ΘNHC(@C6),	173.05(12).	
	
Targeting	the	preparation	of	a	 low-coordinate	bis-NHC	complex	derivative,	2	was	reacted	with	the	halide	
abstracting	agent	Na[BArF4]	in	difluorobenzene	at	reduced	temperature	(253	K).	From	this	reaction,	cationic	
cis-[Rh(IBioxMe4)2(COE)][BArF4]	9	was	isolated	in	good	yield	(71%).	Formally	a	14	valence	electron	complex,	
formation	of	9	was	readily	apparent	by	1H	NMR	spectroscopy	(250	K)	by	a	2H	coordinated	alkene	resonance	
centred	at	δ	3.97,	which	gave	a	strong	HMQC	cross-peak	with	a	13C	signal	at	δ	76.3,	12H	resonances	for	the	
[BArF4]–	 anion	 and	 two	 singlet	 signals	 (8H,	 24H)	 for	 the	 IBioxMe4	 ligands.	 The	 complex	 is	 thus	 highly	
fluxional	in	solution	(500	MHz).	On	the	basis	of	the	low	stability	of	9	(vide	infra)	and	to	reconcile	the	high	
time-averaged	 symmetry	 implicated	 from	 the	 IBioxMe4	 proton	 resonances	 (D2h),	 a	mechanism	 involving	
N N
O
O
Rh ClOC
NN
O
O
N N
O
O
Rh COOC
NN
O
O
N N
O
O
Rh
N
N
O
O
N N
O
O
Rh
N
N
O
O
H
H
2
+
+ +
CO
Na+
C6H6 CH2Cl2
C6H4F2
CO, Na+
C6H4F2
C6H4F2
NBD
CO7 8
9 10
IBioxMe4, Na+5
C6H4F2
	 9	
COE	ligand	dissociation	is	suggested.	Cooling	further	to	200	K	did	not	halt	this	process,	although	the	onset	
of	decoalescence	was	noted	–	particularly	through	resolution	of	inequivalent	methylene	signals	for	the	NHC	
backbone	(see	ESI).		
Subsequent	to	the	NMR	characterisation,	a	relatively	low	quality	solid-state	structure	of	9	was	determined,	
containing	two	crystallographically	independent,	but	structurally	similar	molecules	(Z’	=	2);	one	of	which	is	
shown	 in	 Figure	 3.	 The	 refined	 structure	unambiguously	 confirms	 coordination	of	 the	COE	and	 IBioxMe4	
ligands,	with	9	adopting	an	overall	T-shaped	coordination	geometry.	The	complex	is	stabilised	by	an	agostic	
interaction	 with	 the	 COE	 ligand;	 a	 feature	 that	 is	 much	 more	 pronounced	 in	 one	 of	 the	 independent	
molecules	(Rh1···C4	=	2.56(2)	Å)	than	the	other	(Rh1A···C4A	=	2.94(2)	Å).	Notably,	the	methyl	substituents	
of	 the	 IBioxMe4	 ligand	 remain	 distant	 from	 the	metal	 centre,	with	 the	 closest	 approaches	 having	 Rh···C	
distances	of	3.67(4)	and	3.18(3)	Å	 in	the	 independent	molecules	(containing	Rh1	and	Rh1A,	respectively).	
[Rh(PiBu3)(PtBu2CH2CH2CH=CH2)]+	(G)	34	and	[Rh{((2,6-Me2C6H3)NMeC)2CH}(L)]	(L	=	norbornene	(H),	COE	(I))35	
are	 closely	 related	 rhodium(I)	 alkene	 complexes;	 	G	 and	H	 are	 stabilised	 by	 strong	 agostic	 interactions	
(Rh···C	=	2.41	and	2.53	Å,	respectively),	while	I	is	considered	a	genuinely	low	coordinate	T-shaped	complex	
with	Rh···C distances	of	2.89	and	2.97	Å.	Consistent	with	the	T-shaped	formulation	of	9,	 the	NHC	binding	
trans	 to	 the	 open	 coordination	 site	 does	 so	 with	 a	 significantly	 shorter	 Rh-CNCN	 bond	 distance	 (Rh1,	
1.971(15)	vs	2.099(14)	Å;	Rh1A,	1.921(17)	vs	2.070(15)	Å).		
In	both	CD2Cl2	and	difluorobenzene	solution	at	298	K,	9	undergoes	decomposition	via	loss	of	COE	although	
this	 process	 is	much	 faster	 in	 the	 former	 (t1/2	 =	 0.54	 hrs	 vs.	 6.6	 hrs)	 presumably	 reflecting	 the	 differing	
coordinating	 ability	 of	 the	 two	 solvents;	 the	 resulting	mixtures	 have	 so	 far	 proven	 intractable	 to	 further	
characterisation	in	either	solvent.	Complex	9	does,	however,	act	as	a	source	of	the	reactive	{Rh(IBioxMe4)2}+	
fragment	 in	 solution	 affording	8	 and	 the	diene	 complex	 [Rh(IBioxMe4)2(NBD)][BArF4]	10	 quantitatively	 by	
NMR	spectroscopy	on	addition	of	carbon	monoxide	and	NBD,	respectively	(Scheme	6).	The	formation	of	10	
was	further	verified	by	independent	synthesis	from	5,	IBioxMe4	and	Na[BArF4]	and	the	solid-state	structure	
is	shown	in	Figure	3.		
	
Scheme	7:	Reactions	of	tris-IBioxMe4	complexes.a	
	
a	[BArF4]–	anions	omitted	for	clarity	
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Encouraged	by	the	formation	of	9	from	2,	reaction	of	tris-NHC	complex	3	with	Na[BArF4]	in	CH2Cl2	at	room	
temperature	 led	 to	 the	 isolation	 of	 cationic	 formally	 14	 valence	 electron	 Rh(I)	 complex	
[Rh(IBioxMe4)3][BArF4]	11	in	65%	yield	(Scheme	7,	Figure	4).	Complex	11	can	also	be	prepared	as	previously	
described	using	a	high	yielding	one-pot	procedure	involving	reaction	between	[Rh(COE)2Cl]2	and	IBioxMe4	
in	difluorobenzene,	using	Na[BArF4]	as	a	halide	abstractor	(83%	isolated	yield).13	 In	contrast	to	9,	 the	tris-
NHC	 complex	 was	 found	 to	 be	 completely	 stable	 in	 CD2Cl2	 and	 difluorobenzene	 solution	 at	 room	
temperature	(over	48	hours	under	argon).	This	increased	stability	is	readily	accounted	for	by	the	stronger	
donor	 characteristics	 of	 IBioxMe4	 in	 comparison	 to	 COE	 and	 confirmed	 by	 rapid	 COE	 substitution	 by	
IBioxMe4	on	addition	of	the	NHC	to	9,	forming	11	quantitatively	by	1H	NMR	spectroscopy	(Scheme	7).		
	
	
Figure	4:	Solid-state	structures	of	11	(Z’	=	2).	Thermal	ellipsoids	for	selected	atoms	are	drawn	at	the	50%	
probability	level;	most	hydrogen	atoms,	minor	disordered	components,	anions	and	solvent	molecule	are	
omitted	for	clarity.	Selected	distances:	Rh1-C13,	3.273(3);	Rh1-C29,	3.574(3);	Rh1A-C13A,	3.421(3);	Rh1A-
C29A,	3.191(3).13	
	
As	 noted	 by	 Reed	 reporting	 on	 the	 solid-state	 structure	 of	 [Rh(PPh3)3]+	 (J),	 the	 adoption	 of	 a	 T-shaped	
geometry	is	electronically	favoured	over	trigonal	planar	for	three	coordinate	d8	metal	centres	to	allow	for	
diamagnetism	 (Figure	 5). 36	Moreover,	 T-shaped	 low-coordinate	 d8	 metal	 fragments	 can	 be	 stabilised	
through	formation	of	agostic	 interactions	with	alkyl	 ligand	appendages,	due	to	the	presence	of	accessible	
frontier	orbitals	of	suitable	symmetry	and	energy	(i.e.	b1	and	2a1).	This	facet	is	borne	in	the	solid-state	for	
rhodium(I)	 phosphine	 complexes	 G,	 H,	 J	 (Rh···C	 =	 2.62	 Å),	 [Rh(PiPr3)3]+	 (Rh···C	 =	 2.49	 Å), 37	
[Rh(tBu2PCH2PtBu2)(CH2tBu)]	 (Rh···C	 =	 2.49	 Å)38,	 as	 well	 as	 platinum(II)	 NHC	 and	 phosphine	 complexes	
[Pt(IPr)(IPr’)]+	 (Pt···C	 =	 2.89	 Å)6b	 and	 [Pt(PiPr3)2(Me)]+	 (Pt···C	 =	 2.86	 Å).39	As	 an	 additional	 interesting	
example,	 phosphine-boryl-pincer	 complex	 [Rh{(PtBu2CH2)2(BN2C6H4)}]	 adopts	 intermolecular	 σ-C–H	 bond	
interactions	between	 individual	 complexes	 in	 the	absence	of	accessible	alkyl	groups.40		 In	 the	case	of	11,	
however,	 there	 is	 no	 evidence	 for	 any	 significant	 agostic	 interactions	 between	 the	NHC	 ligands	 and	 the	
metal	centre	in	both	solution	(highly	fluxional	at	298	K)	and	the	solid-state	(Rh···C	distances	for	the	methyl	
substituents	>	3.1	Å).13	Thus,	the	rigid	geometry	of	the	IBioxMe4	ligand	appears	to	prohibit	any	significant	
interaction	of	the	methyl	substituents	in	both	9	and	11.	
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Figure	5:	Frontier	molecular	orbitals	for	d8	metal	centres	in	idealised	trigonal	planar	and	T-shaped	
coordination	geometries.41	
		
Inspection	of	the	IBioxMe4	coordination	geometries	in	9	and	11	reveals	tilted	binding	for	those	cis	to	open	
coordination	 sites:	ΘNHC	 =	 168(1)	 /	 168.4(11)º	 for	9	 and	160.0(2)	 −	 173.1(2)º	 for	11.13	Given	 that	 related	
distortions	observed	in	coordinatively	saturated	2	can	be	confidently	ascribed	to	steric	effects,	and	taking	
into	account	 the	bulky	nature	of	 IBioxMe4	and	 the	absence	any	 significant	Rh···H3C	 interactions	 (Rh···C	≥	
3.18	Å	and	Rh···H	≥	2.44	Å),42	it	 seems	reasonable	 to	similarly	attribute	the	unusual	NHC	geometries	 in	9	
and	11	to	steric	effects.	Related	phenomena	in	main	group	bis-NHC	complexes	of	gallium	and	indium	have	
been	 reported,	 with	ΘNHC	values	 ranging	 from	 144.8	 –	 154.6º,	 and	 attributed	 to	 π-bonding	 interactions	
[s(M)	to	p(CNCN)].18a	Contrasting	with	11,	all	IBioxMe4	ligands	in	coordinatively	saturated	tris-NHC	complexes	
3	 and	 12	 (vide	 infra)	 bind	 with	 and	 ΘNHC	 angles	 >	 175º;	 steric	 interactions	 between	 the	 ancillary	
chloride/carbonyl	ligand	and	the	cis	IBioxMe4	ligands	counteracting	NHC	tilting	(CH3···Cl	=	3.38	–	3.72	Å	cf.	
sum	of	Van	der	Waal	 radii	 =	 3.45	Å;	 CH3···OC	=	 3.35	 –	 3.76	Å	 cf.	 sum	of	Van	der	Waal	 radii	 =	 3.40	Å).13	
Likewise	 in	 the	 context	 of	9,	 only	 slight	 tilting	 is	 observed	 in	10,	 containing	 cis	 IBioxMe4	 ligands	 (ΘNHC	 =	
173.05(12)º).	
As	reported	earlier,	complex	11	shows	no	reaction	with	excess	 IBioxMe4,	PCy3,	or	NBD,	but	reacts	rapidly	
with	 carbon	 monoxide	 to	 generate	 [Rh(IBioxMe4)3(CO)][BArF4],	 12	 (Scheme	 7).13	 Notably,	 the	 static	 C2v	
structure	observed	for	12	in	solution	at	room	temperature	(400	MHz)	contrasts	to	previously	reported	tris-
NHC	 complexes	 [Rh(NHC)3(CO)]+	 	 [NHC	 =	 IiPr2Me2,	 ICy],	 which	 undergo	 restricted	 rotation	 of	 the	 NHC	
ligands	 (about	 Rh-CNCN)	 at	 room	 temperature	 (500	 MHz).43	This	 difference	 in	 behaviour	 is	 presumably	
attributed	 to	 the	 more	 imposing	 steric	 profile	 of	 IBioxMe4	 compared	 to	 IiPr2Me2	 and	 ICy;	 a	 feature	
quantified	by	%Vbur	values	listed	in	Table	1	(ca	32	vs	28).	
Summary	and	Outlook	
A	series	of	new	rhodium(I)	complexes	of	Glorius’	conformationally	rigid	bioxazoline	derived	N-heterocyclic	
carbene	ligand	IBioxMe4	have	been	prepared.	In	contrast	to	non-rigid	ItBu,	complexes	of	IBioxMe4	appear	
to	be	more	resistant	to	cyclometalation	reactions	allowing	the	coordination	of	up	to	three	NHC	ligands	to	
rhodium	via	the	common	(isolated)	dimeric	intermediate	[Rh(IBioxMe4)(COE)Cl]2	(1);	 i.e.	isolation	of	trans-
[Rh(IBioxMe4)2(COE)Cl]	 (2)	 and	 [Rh(IBioxMe4)3Cl]	 (3).	 	 Substitution	 and	 salt	metathesis	 reactions	 of	1	 –	3	
were	 investigated	 and	 derivatives	 containing	 CO,	 norbornadiene	 and	 cyclopentadienyl	 ancillary	 ligands	
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were	 readily	 isolated.	 In	 search	 of	 low-coordinate	 complexes	 of	 IBioxMe4,	 2	 and	 3	 were	 reacted	 with	
Na[BArF4]	and	led	to	the	isolation	of	T-shaped	cis-[Rh(IBioxMe4)2(COE)][BArF4]	(9)	and	[Rh(IBioxMe4)3][BArF4]	
(11).	Although	9	exhibits	low	solution	stability,	readily	losing	COE	at	room	temperature,	11	shows	excellent	
stability.	Using	these	complexes	as	pertinent	examples,	the	rigid	geometry	of	the	IBioxMe4	ligand	appears	
to	preclude	 interaction	of	the	metal	centre	with	the	 ligand’s	alkyl	appendages	as	hypothesised.	The	 large	
steric	profile	of	 IBioxMe4	(%Vbur	=	32.0)	also	 leads	to	 interesting	tilted	NHC	coordination	geometries	 (2,	9	
and	 11).	 The	 electronic	 structure	 and	 additional	 reactivity	 of	 these	 complexes	 is	 currently	 being	
investigated	together	with	that	of	iridium	analogues.	These	results	will	be	reported	in	due	course.	
	
Experimental	
General	experimental	methods	
All	manipulations	were	performed	under	an	atmosphere	of	argon,	using	Schlenk	and	glove	box	techniques.	
Glassware	 was	 oven	 dried	 at	 130ºC	 overnight	 and	 flamed	 under	 vacuum	 prior	 to	 use.	 Anhydrous	 C6H6,	
CH2Cl2,	 heptane	 and	 pentane	 (<0.005	%	H2O)	were	 purchased	 from	ACROS	 or	 Aldrich	 and	 freeze-pump-
thaw	degassed	three	times	before	being	placed	under	argon.	C6D6,	CD2Cl2	and	1,2-difluorobenzene	(C6H4F2)	
were	dried	over	CaH2,	vacuum	distilled	and	the	latter	stored	over	thoroughly	vacuum	dried	3	Å	molecular	
sieves.	Norbornadiene	(NBD)	was	dried	over	Na,	vacuum	distilled	and	stored	over	thoroughly	vacuum	dried	
3	 Å	 molecular	 sieves.	 IBioxMe4.HOTf,11	 [Rh(COE)2Cl]2, 44 	[Rh(NBD)Cl]2 45 	Na[Cp] 46 and	 Na[BArF4] 47 	were	
synthesised	using	literature	procedures.	All	other	solvents	and	reagents	are	commercial	products	and	were	
used	as	received.	NMR	spectra	were	recorded	on	Bruker	DPX-400,	AV-400	and	DRX-500	spectrometers	at	
298	K	unless	otherwise	stated.	Chemical	shirts	are	quoted	in	ppm	and	coupling	constants	in	Hz.	IR	spectra	
were	 recorded	 on	 a	 Perkin-Elmer	 Spectrum	 One	 FT-IR	 spectrometer.	Microanalyses	 were	 performed	 by	
Stephan	Boyer	at	London	Metropolitan	University.			
	
Synthesis	of	new	compounds	
1.1 IBioxMe4	
Prepared	from	IBioxMe4.HOTf	as	described	in	an	earlier	communication.13	
	
1.2 [Rh(IBioxMe4)(COE)Cl]2	(1)	
To	a	suspension	of	[Rh(COE)2Cl]2	(0.100	g,	0.14	mmol)	in	pentane	(30	mL)	was	added	a	solution	of	IBioxMe4	
(0.058	g,	0.28	mmol)	in	pentane	(30	mL)	drop-wise	over	5	minutes.	The	resulting	suspension	was	stirred	at	
room	temperature	for	1	hour	and	then	filtered.	The	filtrate	was	washed	with	pentane	(2		×	10	mL)	and	the	
residue	recrystallised	from	benzene	–	heptane.	Yield	=	0.085	g	(66%,	microcrystalline	cream	solid).		
	
1H	NMR	(C6D6,	400	MHz):	δ	3.76	(d,	2JHH	=	8.1,	2H,	OCH2),	3.71	(d,	2JHH	=	8.1,	2H,	OCH2),	2.89	–	3.05	(m,	2H,	
CH),	2.41	–	2.65	(m,	4H,	CHCH2),	2.02	(s,	6H,	CH3),	1.80	(s,	6H,	CH3),	1.68	–	1.88	(m,	4H,	CH2{COE}),	1.44	–	
1.65	(m,	4H,	CH2{COE}).	13C{1H}	NMR	(C6D6,	101	MHz):	δ	158.3	(d,	1JRhC	=	59,	NCN),	126.4	(s,	COCH2),	87.4	(s,	
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OCH2),	62.2	 (s,	C(CH3)2),	60.4	 (d,	 1JRhC	=	17,	CH),	31.2	 (s,	CH2{COE}),	30.4	 (s,	CHCH2),	27.5	 (s,	CH3),	27.2	 (s,	
CH2{COE}),	 24.9	 (s,	 CH3).	Anal.	 Calcd	 for	 C38H60N4O4Rh2.0.66(C6H6)	 ([913.62]	 965.18	 gmol-1):	 C,	 52.22;	 H,	
6.68;	 N,	 5.80.	 Found:	 C,	 52.21;	 H,	 6.91;	 N,	 5.95.	 Reproducible	 microanalyical	 data	 were	 unable	 to	 be	
obtained	 between	 different	 batches	 of	 this	 product	 due	 the	 presence	 of	 variable	 benzene	 solvate	
(confirmed	by	dissolving	in	CD2Cl2).	1H	and	13C{1H}	NMR	spectra	are	provided	in	the	ESI.		
	
	
1.3 [Rh(IBioxMe4)2(COE)Cl]	(2)	and	[Rh(IBioxMe4)3Cl]	(3)	
To	a	solution	of	[Rh(COE)2Cl]2	 (0.150	g,	0.21	mmol)	 in	benzene	(10	mL)	was	added	a	solution	of	 IBioxMe4	
(0.200	g,	0.960	mmol)	in	benzene	(10	mL)	drop-wise	(over	ca	1	min).	The	resulting	solution	was	stirred	at	
room	temperature	for	24	hours,	during	which	time	3	crystallised.	Complex	3	was	 isolated	by	filtration	and	
washed	with	benzene	 (2	x	2	mL)	–	 the	washings	being	discarded.	Yield	=	0.080	g	 (24%	/	Rh,	deep	yellow	
crystalline	solid).	Addition	of	excess	heptane	to	the	reaction	filtrate	afforded	2.	Yield	=	0.140	g	(47%	/	Rh,	
yellow	microcrystalline	 solid).	 Higher	 yields	 of	3	 can	 be	 achieved	 using	 a	 larger	 excess	 of	 IBioxMe4,	 e.g.	
repeating	using	8	equivalents	of	ligand	gave	a	55%	yield	of	3	after	24	hours.	
	
Data	for	2:	
1H	NMR	(C6D6,	400	MHz):	δ	3.93	(d,	2JHH	=	7.9,	4H,	OCH2),	3.80	(d,	2JHH	=	7.9,	4H,	OCH2),	3.19	–	3.28	(m,	2H,	
CH),	 2.50	 –	 2.61	 (m,	 2H,	 CHCH2),	 2.13	 (s,	 12H,	 CH3),	 1.77	 (s,	 12H,	 CH3),	 1.71	 –	 1.85	 (obscured	 m,	 4H,	
CH2{COE}),	1.52	–	1.62	(m,	4H,	CHCH2	+	CH2{COE}),	1.39	–	1.52	(m,	2H,	CH2{COE}).	13C{1H}	NMR	 (C6D6,	101	
MHz):	δ	169.6	(d,	1JRhC	=	42,	NCN),	126.5	(s,	COCH2),	87.8	(s,	OCH2),	62.5	(s,	C(CH3)2),	57.7	(d,	1JRhC	=	16,	CH),	
34.4	 (s,	 CHCH2),	 31.7	 (s,	 CH2{COE}),	 27.2	 (s,	 CH2{COE}),	 26.7	 (s,	 CH3),	 24.4	 (s,	 CH3).	 Anal.	 Calcd	 for	
C30H46ClN4O4Rh.0.5(C6H6)	 ([665.07]	704.13	gmol-1):	C,	56.29;	H,	7.01;	N,	7.96.	Found:	C,	56.18;	H,	7.07;	N,	
8.17.	 Benzene	 solvate	 is	 readily	 apparent	 from	 the	 crystal	 structure	 and	 on	 dissolving	 in	 CD2Cl2	 (not	
stable).48	
	
Data	for	3:	
1H	NMR	(C6D6,	400	MHz):	δ	4.00	(d,	2JHH	=	7.4,	4H,	OCH2),	3.97	(d,	2JHH	=	7.4,	4H,	OCH2),	3.89	(d,	2JHH	=	7.7,	
4H,	OCH2),	3.82	(d,	2JHH	=	7.7,	4H,	OCH2),	3.74	(s,	4H,	OCH2),	2.34	(s,	6H,	CH3),	2.33	(s,	6H,	CH3),	2.27	(s,	6H,	
CH3),	2.18	(s,	6H,	CH3),	0.76	(s,	6H,	CH3),	0.55	(s,	6H,	CH3).	13C	NMR	(C6D6,	101	MHz):	concentration	was	too	
low	 to	measure.	Anal.	Calcd	 for	C33H48ClN6O6Rh.0.25(C6H6)	 ([763.13]	782.66	gmol-1):	C,	52.94;	H,	6.37;	N,	
10.75.	 Found:	 C,	 52.72;	 H,	 6.38;	 N,	 10.68.	 Benzene	 solvate	 was	 confirmed	 by	 dissolving	 in	 CD2Cl2	 (not	
stable).	
	
1.4 	cis-[Rh(IBioxMe4)(CO)2Cl]	(4)	
A	solution	of	1	(0.050	g,	0.055	mmol)	in	benzene	(2	mL)	was	placed	under	CO	(1	atm)	and	stirred	at	room	
temperature	for	10	minutes.	The	solution	was	placed	under	argon	and	the	product	crystallised	by	addition	
of	excess	heptane	(ca	40	mL)	and	cooling	to	5ºC.	Yield	=	0.040	g	(90%,	pale	yellow	microcrystalline	solid).	
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1H	NMR	(C6D6,	400	MHz):	δ	3.66	(d,	2JHH	=	8.3,	2H,	CH2),	3.61	(d,	2JHH	=	8.3,	2H,	CH2),	1.51	(s,	12H,	CH3),	1.25	
(s,	12H,	CH3).	13C{1H}	NMR	 (C6D6,	101	MHz):	δ	186.7	(d,	1JRhC	=	55,	CO),	183.9	(d,	1JRhC	=	73,	CO),	149.4	(d,	
1JRhC	=	42,	NCN),	126.2	(s,	COCH2),	87.3	(s,	CH2),	61.3	(s,	C(CH3)2),	26.7	(s,	CH3),	25.2	(s,	CH3).	IR	(CH2Cl2,	cm-1):	
ν(CO)	2081	(s),	2000	(s).	Anal.	Calcd	for	C13H16ClN2O4Rh	(402.64	gmol-1):	C,	38.78;	H,	4.01;	N,	6.96.	Found:	C,	
38.83;	H,	4.04;	N,	6.88.	
	
1.5 [Rh(IBioxMe4)(NBD)Cl]	(5)	
To	a	mixture	of	[Rh(NBD)Cl]2	(0.100	g,	0.22	mmol)	and	IBioxMe4	(0.100	g,	0.48	mmol)	was	added	benzene.	
The	resulting	suspension	was	stirred	at	room	temperature	for	2	hours	before	the	volatiles	were	removed	in	
vacuo.	The	 residue	was	 chromatographed	on	 silica	using	1:3	THF	–	CH2Cl2	 (in	air)	 and	 then	 recrystallised	
from	CH2Cl2	–	hexane.	Yield	=	0.168	g	(88%,	yellow	microcrystalline	solid).	
	
1H	NMR	(CD2Cl2,	400	MHz):	δ	4.69	(app	q,	J	=	2,	2H,	CH=CH),	4.47	(d,	2JHH	=	8.2,	2H,	OCH2),	4.42	(d,	2JHH	=	8.2,	
2H,	OCH2),	3.78	(br,	2H,	CH2CH),	3.56	(app	q,	J	=	2,	2H,	CH=CH),	1.98	(s,	6H,	CH3),	1.89	(s,	6H,	CH3),	1.37	(td,	
2JHH	=	8.2,	 3JHH	=	1,	1H,	CH2{NBD}),	 1.30	 (dt,	 2JHH	=	8.2,	 3JHH	=	1,	1H,	CH2{NBD}).	 13C{1H}	NMR	 (CD2Cl2,	 101	
MHz):	δ	162.3	(d,	1JRhC	=	56.5,	NCN),	126.1	(s,	COCH2),	88.0	(OCH2),	76.9	(d,	1JRhC	=	6,	CH=CH),	63.9	(d,	3JRhC	=	
5,	CH2{NBD}),	61.9	(s,	C(CH3)2),	51.3	(s,	CH2CH),	49.2	(d,	1JRhH	=	12,	CH=CH),	27.1	(s,	CH3),	26.0	(s,	CH3).	Anal.	
Calcd	for	C18H24ClN2O2Rh	(438.75	gmol-1):	C,	49.27;	H,	5.51;	N,	6.38.	Found:	C,	49.29;	H,	5.81;	N,	6.22.	
	
1.6 [Rh(IBioxMe4)(Cp)(COE)]	(6)	
A	suspension	of	1	(0.060	g,	0.066	mmol)	and	Na[Cp]	(0.012	g,	0.140	mmol)	in	CH2Cl2	(2	mL)	was	stirred	at	
room	 temperature	 for	 3	 hours.	 The	 volatiles	 were	 removed	 in	 vacuo	 and	 the	 product	 obtained	 by	
extraction	of	the	residue	with	heptane	(2		×	5	mL).	Yield	=	0.052	g	(72%,	yellow	powder).		
	
1H	NMR	(C6D6,	400	MHz):	δ	5.11	(s,	5H,	Cp),	3.70	(d,	2JHH	=	8.1,	2H,	OCH2),	3.67	(d,	2JHH	=	8.1,	2H,	OCH2),	2.48	
–	2.58	(m,	2H,	CHCH2),	2.06	–	2.15	(m,	2H,	CH),	1.70	–	1.95	(m,	6H,	CH2{COE}),	1.75	(s,	6H,	CH3),		1.48	–	1.62	
(m,	4H,	CH2{COE}),	1.32	 (s,	6H,	CH3).	 13C{1H}	NMR	 (C6D6,	101	MHz):	δ	159.7	 (d,	 1JRhC	=	66,	NCN),	125.6	 (s,	
COCH2),	87.2	(s,	OCH2),	86.2	(d,	 1JRhC	=	3,	Cp),	62.4	(s,	C(CH3)2),	53.1	(d,	 1JRhC	=	17,	CH),	34.7	(s,	CH2{COE}),	
33.9	(s,	CH2{COE}),	27.3	(s,	CH2{COE}),	27.3	(s,	CH3),	23.2	(s,	CH3).	Anal.	Calcd	for	C24H35N2O2Rh	(486.45	gmol-
1):	C,	59.26;	H,	7.25;	N,	5.76.	Found:	C,	59.40;	H,	7.35;	N,	5.83.		
	
1.7 trans-[Rh(IBioxMe4)2(CO)Cl]	(7)	
A	solution	of	2	(0.050	g,	0.071	mmol)	in	benzene	(2	mL)	was	placed	under	CO	(1	atm)	and	stirred	at	room	
temperature	for	24	hours.	The	volatiles	were	removed	in	vacuo	and	the	crude	product	recrystallised	from	
CH2Cl2	–	heptane	at	room	temperature.	Yield	=	0.	035	g		(85%,	pale	yellow	microcrystalline	solid).			
	
1H	NMR	 (CD2Cl2,	400	MHz):	δ	4.56	(d,	2JHH	=	8.3,	4H,	CH2),	4.52	(d,	2JHH	=	8.3,	4H,	CH2),	1.93	(s,	12H,	CH3),	
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1.91	 (s,	12H,	CH3).	 13C{1H}	NMR	 (CD2Cl2,	101	MHz):	δ	 188.0	 (d,	 1JRhC	=	82,	CO),	160.5	 (d,	 1JRhC	=	39,	NCN),	
125.5	(s,	COCH2),	88.6	(s,	CH2),	61.3	(s,	C(CH3)2),	27.3	(s,	CH3),	26.3	(s,	CH3).	IR	(CH2Cl2,	cm-1):	ν(CO)	1942	(s).	
Anal.	Calcd	for	C23H32ClN4O5Rh	(582.88	gmol-1):	C,	47.39;	H,	5.53;	N,	9.61.	Found:	C,	47.41;	H,	6.04;	N,	9.69.	
	
1.8 trans-[Rh(IBioxMe4)2(CO)2][BArF4]	(8)	
A	suspension	of	7	(0.020	g,	0.034	mmol)	and	Na[BArF4]	(0.034	g,	0.038	mmol)	in	CH2Cl2	was	placed	under	CO	
(1	 atm)	 and	 stirred	 at	 room	 temperature	 for	 30	 minutes.	 The	 reaction	 was	 placed	 under	 an	 argon	
atmosphere,	the	solution	filtered	and	the	filtrate	layered	with	heptane	to	afford	a	crystalline	product	upon	
diffusion.	Yield	=	0.034	g	(70%,	yellow	crystals).		
	
1H	NMR	 (CD2Cl2,	400	MHz):	δ	7.69	–	7.73	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	4.63	(s,	8H,	OCH2),	1.80	(s,	24H,	
CH3).	1H	NMR	(C6H4F2,	500	MHz):	δ	8.34	(br,	8H,	ArF),	7.70	(br,	4H,	ArF),	4.58	(s,	8H,	OCH2),	1.91	(s,	24H,	CH3).	
13C{1H}	NMR	(CD2Cl2,	101	MHz):	δ	185.4	(d,	1JRhC	=	64,	CO),	162.3	(q,	1JBC	=	50,	ArF),	141.0	(d,	1JRhC	=	37,	NCN),	
135.4	(s,	ArF),	129.4	(qq,	2JFC	=	32,	3JBC	=	3,	ArF),	128.4	(s,	COCH2),	125.2	(q,	1JFC	=	272,	ArF),	118.0	(sept,	3JFC	=	
4,	 ArF),	 88.1	 (OCH2),	 61.9	 (s,	 C(CH3)2),	 26.8	 (s,	 CH3).	 IR	 (CH2Cl2,	 cm-1):	 ν(CO)	 2024	 (s).	 Anal.	 Calcd	 for	
C56H44BF24N4O6Rh	(1438.65	gmol-1):	C,	46.75;	H,	3.08;	N,	3.89.	Found:	C,	46.91;	H,	2.96;	N,	4.08.	
	
1.9 cis-[Rh(IBioxMe4)2(COE)][BArF4]	(9)	
In	an	inert	atmosphere	glove	box,	cold	C6H4F2	(1.5	mL,	-20ºC)	was	added	to	a	mixture	of	2	(0.060	g,	0.090	
mmol)	and	Na[BArF4]	(0.088	g,	0.099	mmol).	The	resulting	suspension	was	held	at	-20ºC	for	10	minutes	with	
periodic	 shaking.	 The	mixture	was	 diluted	with	 cold	 heptane	 (-20ºC)	 and	 rapidly	 filtered	 through	 celite.	
Addition	 of	 excess	 cold	 heptane	 resulted	 in	 the	 precipitation	 of	 the	 product,	 which	 was	 subsequently	
washed	with	cold	heptane	(2	x	2	mL)	and	dried	in	vacuo.	Yield	=	0.095	g	(71%,	light	red-brown	solid).	The	
sample	for	NMR	analysis	was	prepared	by	vacuum	transfer	of	CD2Cl2	into	a	J	Young’s	NMR	tube	containing	
the	solid	product	cooled	to	-196ºC.	The	complex	dissolved	on	warming	the	tube	to	-78ºC;	the	sample	was	
then	transferred	directly	into	a	NMR	spectrometer	pre-cooled	to	-23ºC	(250	K).		
	
1H	NMR	(CD2Cl2,	500	MHz,	250	K):	δ	7.68	–	7.72	(m,	8H,	ArF),	7.54	(br,	4H,	ArF),	4.44	(s,	8H,	CH2),	3.93	–	4.01	
(m,	 2H,	 CH),	 2.46	 –	 2.56	 (m,	 2H,	 CHCH2),	 1.66	 (s,	 24H,	 CH3),	 1.17	 –	 1.75	 (m,	 10H,	 CH2{COE};	δ	 1.29,	 2H,	
CHCH2’).	1H	NMR	(C6H4F2,	500	MHz,	298	K):	δ	8.34	(br,	8H,	ArF),	7.70	(br,	4H,	ArF),	4.45	(s,	8H,	CH2),	4.24	–	
4.31	 (m,	2H,	CH),	2.29	–	2.38	 (m,	2H,	CHCH2),	1.62	 (s,	24H,	CH3),	1.26	–	1.85	 (m,	10H,	CH2{COE}).	 13C{1H}	
NMR	 (CD2Cl2,	126	MHz,	250	K):	δ	 161.9	 (q,	1JBC	=	50,	ArF),	134.9	 (s,	ArF),	128.9	 (qq,	2JFC	=	32,	3JBC	=	3,	ArF),	
126.8	 (br,	 COCH2),	 124.7	 (q,	1JFC	=	 272,	 ArF),	 117.7	 (sept,	3JFC	=	 4,	 ArF),	 87.6	 (s,	 CH2),	 76.3	 (very	 br	 –	 from	
HMQC,	CH),	62.7	(s,	C(CH3)2),	30.2	(br,	CHCH2)	30.0	(s,	CH2{COE}),	26.0	(s,	CH2{COE}),	25.6	(br,	CH3).	The	NCN	
resonance	was	not	observed,	presumably	it	is	very	broad.	Anal.	Calcd	for	C62H58BF24N4O4Rh	(1492.83	gmol-
1):	C,	49.88;	H,	3.92;	N,	3.75.	Found:	C,	49.74;	H,	3.87;	N,	3.90.	
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1.10 [Rh(IBioxMe4)2(NBD)][BArF4]	(10)	
To	a	mixture	of	5	(0.056	g,	0.13	mmol),	IBioxMe4	(0.030	g,	0.14	mmol)	and	Na[BArF4]	(0.124	g,	0.14	mmol)	
was	 added	C6H4F2	 (2	mL)	 and	 the	 resulting	 suspension	 stirred	 at	 room	 temperature	 for	 90	minutes.	 The	
solution	 was	 filtered	 and	 the	 product	 crystallised	 by	 addition	 of	 excess	 heptane.	 Yield	 =	 0.150	 g	 (78%,	
yellow	–	orange	microcrystalline	solid).	
	
1H	NMR	(CD2Cl2,	400	MHz):	δ	7.70	–	7.74	(m,	8H,	ArF),	7.57	(br,	4H,	ArF),	4.60	(app	q,	J	=	2,	4H,	CH=CH),	4.44	
(d,	2JHH	=	8.3,	4H,	OCH2),	4.40	(d,	2JHH	=	8.3,	4H,	OCH2),	3.92	(br,	2H,	CH2CH),	1.87	(s,	12H,	CH3),	1.60	(s,	12H,	
CH3),	1.49	(t,	3JHH	=	1,	2H,	CH2{NBD}).1H	NMR	(C6H4F2,	500	MHz):	δ	8.34	(br,	8H,	ArF),	7.70	(br,	4H,	ArF),	4.73	
(app	q,	J	=	2,	4H,	CH=CH),	4.43	(d,	2JHH	=	8.4,	4H,	OCH2),	4.39	(d,	2JHH	=	8.4,	4H,	OCH2),	3.95	(br,	2H,	CH2CH),	
1.94	 (s,	 12H,	CH3),	 1.70	 (s,	 12H,	CH3),	 1.53	 (t,	 3JHH	=	1,	 2H,	CH2{NBD}).	 13C{1H}	 NMR	 (CD2Cl2,	 101	MHz):	δ	
162.3	(q,	1JBC	=	50,	ArF),	157.0	(d,	1JRhC	=	57,	NCN),	135.4	(s,	ArF),	129.4	(qq,	2JFC	=	32,	3JBC	=	3,	ArF),	127.4	(s,	
COCH2),	125.2	(q,	1JFC	=	272,	ArF),	118.0	(sept,	3JFC	=	4,	ArF),	88.7	(OCH2),	67.9	(d,	1JRhC	=	8,	CH=CH),	66.9	(d,	
3JRhC	 =	 4,	 CH2{NBD}),	 63.8	 (s,	 C(CH3)2),	 52.6	 (s,	 CH2CH),	 27.6	 (s,	 CH3),	 24.4	 (s,	 CH3).	 Anal.	 Calcd	 for	
C61H52BF24N4O4Rh	(1474.77	gmol-1):	C,	49.68;	H,	3.55;	N,	3.80.	Found:	C,	49.87;	H,	3.46;	N,	3.90.	
	
1.11 [Rh(IBioxMe4)3][BArF4]	(11)	
To	a	mixture	of	3	(0.100	g,	0.131	mmol)	and	Na[BArF4]	(0.128	g,		0.144	mmol)	was	added	CH2Cl2	(4	mL).	The	
resulting	 dark	 purple	 solution	 was	 filtered	 and	 the	 filtrate	 layered	 with	 heptane	 to	 afford	 a	 crystalline	
product	 upon	 diffusion.	 Yield	 =	 0.140	 g	 (65%,	 purple	 crystals).	 Complex	 11	 can	 also	 be	 made	 from	
[Rh(COE)2Cl]2	and	IBioxMe4	in	difluorobenzene,	using	Na[BArF4]	as	a	halide	abstractor	(83%	isolated	yield).	
Details	of	this	alternative	procedure	and	NMR	data	were	reported	earlier.13	
	
1.12 [Rh(IBioxMe4)3(CO)][BArF4]	(12)	
Prepared	from	11	as	described	in	an	earlier	communication.13		IR	(CH2Cl2,	cm-1):	ν(CO)	1968	(s).	
	
Supporting	information	
Experimental	details	for	NMR	scale	reactions,	selected	NMR	spectra	of	1	–	10,	crystallographic	data	and	the	
structure	 of	 [Rh(IBioxMe4)2Cl2].	 This	 material	 is	 available	 free	 of	 charge	 via	 the	 Internet	 at	
http://pubs.acs.org.	Full	crystallographic	details	are	document	in	CIF	format	and	have	been	deposited	with	
the	Cambridge	Crystallographic	Data	Centre	under	CCDC	972199	–	972208	and	994089	([Rh(IBioxMe4)2Cl2]	
see	ESI).	
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